241 related articles for article (PubMed ID: 10429806)
1. [Conjugated pneumococcal vaccines].
Reinert P
Arch Pediatr; 1999; 6 Suppl 3():643s-646s. PubMed ID: 10429806
[No Abstract] [Full Text] [Related]
2. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Hernández-Delgado L; Lavalle-Villalobos A; Casas-Muñoz A; Cervantes-Apolinar Y; Moreira M; Schuerman L
Hum Vaccin; 2011 Nov; 7(11):1137-45. PubMed ID: 22048109
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.
Rennels MB; Edwards KM; Keyserling HL; Reisinger KS; Hogerman DA; Madore DV; Chang I; Paradiso PR; Malinoski FJ; Kimura A
Pediatrics; 1998 Apr; 101(4 Pt 1):604-11. PubMed ID: 9521941
[TBL] [Abstract][Full Text] [Related]
5. Current status and prospects for some improved and new bacterial vaccines.
Robbins FC; Robbins JB
Annu Rev Public Health; 1986; 7():105-25. PubMed ID: 3521639
[No Abstract] [Full Text] [Related]
6. Current immunization practices. 2. Hemophilus influenzae, pneumococcal, and meningococcal infections, rabies, and hepatitis.
Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
Postgrad Med; 1989 Feb; 85(2):199-202, 207-10. PubMed ID: 2783778
[No Abstract] [Full Text] [Related]
7. Sustaining immunity after immunization against encapsulated bacteria.
Blanchard-Rohner G; Pollard AJ
Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
10. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
11. Developing and deploying pneumococcal and haemophilus vaccines.
Steinhoff MC
Lancet; 1993 Sep; 342(8872):630-1. PubMed ID: 8103141
[No Abstract] [Full Text] [Related]
12. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
13. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae.
Lipsitch M
Emerg Infect Dis; 1999; 5(3):336-45. PubMed ID: 10341170
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.
Zangwill KM; Greenberg DP; Chiu CY; Mendelman P; Wong VK; Chang SJ; Partridge S; Ward JI
Vaccine; 2003 May; 21(17-18):1894-900. PubMed ID: 12706674
[TBL] [Abstract][Full Text] [Related]
16. Disease transmission: routes, contributing factors and herd immunity.
O'Brien K
Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363
[No Abstract] [Full Text] [Related]
17. The Incidence of Pediatric Invasive Bacterial Diseases in Nippon Medical School Chiba Hokusoh Hospital before and after the Introduction of Conjugate Vaccines.
Sano T; Suzuki T; Nishigori A; Miyatake C; Koizumi S; Kaizu K; Fujita A; Kamisago M; Chang B; Ishiwada N; Asano T
J Nippon Med Sch; 2018; 85(1):34-38. PubMed ID: 29540644
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.
Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; Brown NJ; McIntyre P; Smith-Vaughan H; Skull S; Balloch A; Andrews R; Carapetis J; McDonnell J; Krause V; Morris PS
BMJ Open; 2015 Jan; 5(1):e007247. PubMed ID: 25596202
[TBL] [Abstract][Full Text] [Related]
19. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
Block SL; Hedrick J; Harrison CJ; Tyler R; Smith A; Findlay R; Keegan E
Pediatr Infect Dis J; 2004 Sep; 23(9):829-33. PubMed ID: 15361721
[TBL] [Abstract][Full Text] [Related]
20. New vaccine targets childhood pneumonia.
Stephenson J
JAMA; 1999 Nov; 282(20):1905. PubMed ID: 10580443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
